12

ANNUAL REPORT 2013-2014

In the able hands of Andy Gray as chairman, the BPP

has facilitated cooperation between its different

sections, and the merger of the Laboratory and

Medicines Control Section with the Industrial

Pharmacy Section was finalised.

I look forward to working with all FIP officers to take

on the challenge of steering the BPP towards the

future described in the 2020 Vision.

Ema Paulino

Professional secretary

Healthcare systems are struggling throughout the world. While developing countries strive to provide universal healthcare, most developed countries are dealing with unsustainable rising costs, uneven access to services and faltering quality of care.

The adequate use of resources is fundamental to

ensuring that systems are capable of responding to

changing healthcare needs. And this includes

guaranteeing that medicines are used responsibly.

The Board of Pharmaceutical Practice (BPP), through

its eight sections, is devoted to advancing pharma-

ceutical practice in all fields. In the past year, special

emphasis has been given to discussing how ethics

and professional autonomy can safeguard individual

patient interest, and how remuneration systems can

expedite pharmacists contributions to positive

clinical and economic outcomes.

Responsible use of medicines can best be achieved

through constructive collaboration between all

stakeholders. Therefore, the BPP has continued to

invest in building a strong partnership with the Board

of Pharmaceutical Sciences, as well as with the FIP

Education Initiative. Guaranteeing that pharmaceu-

tical scientists, pharmacists and educators are

aligned in their objectives and strategies is vital to

ensuring success. This has been achieved through

combined congress programming, as well as through

a joint working group on pharmaceuticals and the

environment.

FOCUS ON AUTONOMY, REMUNERATION AND COLLABORATION

NOTES FROM THE BOARD OF PHARMACEUTICAL PRACTICE